Skip to main content
. 2005 Jul;58(7):734–739. doi: 10.1136/jcp.2004.023531

Table 5.

 Immunohistochemical staining patterns of p21, p16, and p53 in patients with non-small cell lung cancer

Cyclin D1 pRb2/p130 p16 No. of patients Group
+ + 24
+ 22 A (59)
+ 4
+ + + 9
+ + 18
+ + 6 B (25)
1
+ 21 C (21)

Group A, no or only one adverse prognostic factor; group B, two adverse prognostic factors; group C, three adverse prognostic factors.